Abstract:OBJECTIVE:To investigate the expression of fascin and cytokeratin 14 (CK14) in human esophageal squamous cell carcinoma (ESCC) and the association of these two proteins with ESCC malignant progression and the possibility of application of these 2 proteins in the diagnosis of ESCC.METHODS:A tissue microarray composed of the representative regions of ESCC and corresponding normal epithelium was constructed. Immunohistochemistry was conducted to examine the expression of fascin and CD14 in 116 specimens of ESCC and the normal tissues near the cancerous tissues. The relation of these two proteins with the invasive depth, node involvement, differentiated grade, pTNM stages was analyzed. Disease-free survival analysis was carried out using Kaplan-Meier method. The correlation of the two proteins was analyzed using Spearman's correlation test. ESCC cells of the lines EC9706, TE12, COLO-680N, KYSE510, KYSE450, KYSE410, KYSE180, KYSE150, KYSE140, KYSE70, KYSE30, and YES2 were cultured and underwent SDS-PAGE and Western blotting to examine the expression of fascin and CD14. And the correlation of the two proteins with the characteristics of the cell lines was analyzed too.RESULTS:Fascin and CK14 were negative in the normal esophageal epithelia except in the basal cells. The positive rates of fascin and CK14 in the ESCC cells were 79.3% and 67.0% respectively. The positive rate of either fascin or CK14 was 86.2%. The expression rates of fascin and CK14 in well- and moderately-differentiated ESCCs were significantly higher than that in the poorly-differentiated ones (P = 0.054 and P < 0.01). The patients with positive expression of fascin and those with negative expression of CK14 had a poorer survival in comparison with those with negative fascin expression and those with positive CK14 expression respectively, however, without statistical significances (P = 0.8980 and P = 0.2610). The positive rates of fascin in the well-, moderately-, and poorly- differentiated ESCCs were 87.1%, 83.9%, and 62.1% respectively (P = 0.054). The positive rates of CK14 in the well-, moderately-, and poorly-differentiated ESCCs were; 87.1%, 76.4%, and 27.6% respectively (P < 0.01). The prognosis was not significantly correlated with the expression of both proteins (P = 0.8980 and P = 0.2610). There was an significantly positive correlation between the expression levels of these 2 proteins (r = 0.487, P < 0.01). Fascin was highly expressed in most of the ESCC lines, except in the slowly growing and weakly migrating TE12 line. High expression of CK14 was only seen in the line KYSE180.CONCLUSION:Fascin and CK14 may play important roles in the carcinogenesis and progression of ESCC. Combination of fascin and CK14 would be valuable markers in diagnosis of ESCC.

Expression of Fas ligand contributes to formation of immune escape in esophageal carcinoma

[Expression of Fas, Fas Ligand, Fas-associated Death Domain Protein, Caspase 8 and Mutant P53 Protein in Esophageal Squamous Cell Carcinoma].

FasL Expression in Human Colon Carcinomas

Fas Ligand Expression in Colon Cancer: A Possible Mechanism of Tumor Immune Privilege

[Expression of Fascin and Cytokeratin 14 in Esophageal Squamous Cell Carcinoma].

Influence of FasL gene expression on hepatic metastasis of colorectal carcinoma

[The influence of FasL gene expression upon hepatic metastasis of colorectal carcinoma]

Expression Status of Fatty Acid Synthase (FAS) but Not HER2 is Correlated with the Differentiation Grade and Prognosis of Esophageal Carcinoma.

Loss of Fas Expression and High Expression of HLA-E Promoting the Immune Escape of Early Colorectal Cancer Cells.

Considering Fas ligand as a target for therapy.

The Expression of Fas,FasL in Laryngeal Carcinoma and Its Clinical Significance

The Fas Expression in Gastric Cancer Cells and Peripheral Lymphocytes

The effect of Fas/FasL's expression in hepatocellular carcinoma with HBV infection

Expression of Fas/Fasl Gene Protein and Its Chinical Significance in Human Non-small Cell Lung Cancer

Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back.

Fas-mediated Pathway and Apoptosis in Normal Cervix, Cervical Intraepithelial Neoplasia and Cervical Squamous Cancer.

Activated T cell exosomes promote tumor invasion via Fas signaling pathway.

[Porphyromonas gingivalis infection facilitates immune escape of esophageal cancer by enhancing YTHDF2-mediated Fas degradation]

VEGF-C Expression and Clinical Significance in Esophageal Squamous Cell Carcinoma

Fas Signaling Promotes Gastric Cancer Metastasis Through STAT3-Dependent Upregulation of Fascin.

Effect of Selenium on the Expression of Fas/FasL in T Lymphocyte Anti Colonic Cancer Cells